-
Photovoltaic 24
-
Wind energy 6
-
Other renewable energy (nuclear, geothermal, etc.) 22
-
Grid/power transmission 23
-
Energy storage 31
-
Hydrogen energy 10
-
Lithium batteries 48
-
Electric vehicles 45
-
Low-carbon buildings and construction 7
-
Agriculture 11
-
Low-carbon consumer goods 6
-
New materials 22
-
Industrial manufacturing 7
-
Green transportation 22
-
CCUS 2
-
Digital technology for carbon accounting and consulting 22
-
Bio-Tech 2
-
Circular economy 31
All investors
114 institutional investors
Content Filter
-
Photovoltaic 24
-
Wind energy 6
-
Other renewable energy (nuclear, geothermal, etc.) 22
-
Grid/power transmission 23
-
Energy storage 31
-
Hydrogen energy 10
-
Lithium batteries 48
-
Electric vehicles 45
-
Low-carbon buildings and construction 7
-
Agriculture 11
-
Low-carbon consumer goods 6
-
New materials 22
-
Industrial manufacturing 7
-
Green transportation 22
-
CCUS 2
-
Digital technology for carbon accounting and consulting 22
-
Bio-Tech 2
-
Circular economy 31
-
Junsan Capital
- Investments: 141
- Funds: 31
- Shenzhen, Guangdong Province
-
Energy storage
-
New materials
-
Digital technology for carbon accounting and consulting
Junsan Capital, founded in 2003, is a pioneer in China's domestic direct equity investment market, the earliest domestic professional institution to carry out equity investment business through trust platforms, and an innovator who leads the design and implementation of the first PE unit trust fund in China . In response to the capital market changes, Junsan Capital has expanded from PE to VC business. Since our establishment, we have managed a total of over 12 billion funds and invested in over 100 high-quality companies, of which nearly 45 have exited through IPOs, mergers and acquisitions, and backdoors. Junsan Capital focuses on emerging technological fields such as information technology, corporate services, financial technology, advanced manufacturing, and consumer health technology. We aim at helping entrepreneurs with dreams change the world together!
-
Sequoia Capital
- Investments: 1545
- Funds: 199
- Tianjin
-
Photovoltaic
-
Lithium batteries
-
Wind energy
-
Electric vehicles
-
Grid/power transmission
-
Agriculture
-
Industrial manufacturing
-
CCUS
-
Digital technology for carbon accounting and consulting
-
Circular economy
Sequoia China was founded in September 2005 by Zhang Fan, Shen Nanpeng and Sequoia Capital. Sequoia China aims at high-quality and fast-growing companies, and focuses on four directions: technology and media, consumer goods and modern service industry, health industry, energy and environmental protection. Sequoia China currently manages a total of seven funds with a total amount of about 2 billion US dollars and about 4 billion yuan, which are used to invest in high-growth enterprises in China. Sequoia China's major investment projects include ZTO, Alibaba, 360, Wanda Movies, JD, Eleme, Toutiao, Sinnet and so on.
-
K2VC
- Investments: 688
- Funds: 11
- Beijing
-
Energy storage
-
Hydrogen energy
-
Low-carbon buildings and construction
-
Low-carbon consumer goods
-
CCUS
-
Digital technology for carbon accounting and consulting
-
Other renewable energy (nuclear, geothermal, etc.)
Founded in 2010, K2VC focuses on early investment in the new economy, and is committed to promoting technological progress, business model innovation and the evolution of people's lifestyles. Our subsidiaries cover investment in the Internet, consumption, medicine, and other fields. We have invested in more than 500 high-growth entrepreneurial enterprises, covering angel to B round and managing RMB and US dollar dual-currency funds. Our K2VC Foundation is dedicated to identifying and supporting future leaders in China's public welfare sector and has supported more than 70 public welfare organizations and social enterprises. With the mission of "Empowering the young people creating the future", we support and accompany outstanding entrepreneurs to climb the peak and devote to the great progress of business and technology.
-
Tech Capital
- Investments: 8
- Funds: 0
- Jiaxing City, Zhejiang Province
-
New materials
-
Circular economy
Tech Capital is a four-in-one platform that provides scientific and technological innovation services, incubation of scientific and technological achievements, scientific and technological investment and technology trading for hard science and technology entrepreneurs. Relying on the scientific research strength of top science institutes and universities at home and abroad and the rich industrial resources and capital market experience of advantagous capitals, Tech Capital offers professional, in-depth and comprehensive investment, incubation and financing solutions for science and technology entrepreneurs, and is committed to building a platform for the industrialization of science and technology, technicalization of industry, clustering of science and technology, technology trading and combination of industry and investment. It helps turn science and technology into productivity, uses the power of capital to build a strong science and technology nation, equips industrial entities with science and technology and capitalizes science and technology enterprises, and supports cutting-edge science and technology enterprises in all areas, from intellectual property development to initial public offerings (IPO).
-
Hankang Capital
- Investments: 75
- Funds: 13
- Shanghai
-
Photovoltaic
-
Grid/power transmission
-
Digital technology for carbon accounting and consulting
Hankang Capital (formerly "Shanghai Jianxin Capital") is a venture capital focusing on the biomedical industry. We pay attention to major diseases and major clinical needs, carry out in-depth research, support pioneering companies with first-class team and technology platform in advance, and provide professional insights, experience and resources in product pipeline, team building, application and registration, clinical trials, etc. to promote them to become leading enterprises in the industry as soon as possible. We have invested in Innocare Pharma Limited, Akeso, Chip Screen, Keymed Biosciences, AbbiskoTherapeutics and other industry leading companies. Hankang Capital has won the honors such as "TOP 100 Venture Capital Institutions", "TOP 20 Healthcare Investment Institutions", and "TOP 50 Venture Capital Institutions Recognized by LP in China" for many times.